Speaker

Mikael Rydén gained his M.D. at the Karolinska Institute in 1996 and defended his PhD the following year. He became specialist in internal medicine in 2005, endocrinology/diabetology in 2006 and was appointed professor in clinical and experimental adipose tissue research at the Karolinska Institute in 2013. His research focuses on white fat cells and their relevance for the development of insulin resistance and type 2 diabetes. He heads the Endocrinology unit at the Department of Medicine as well as of the Center for Clinical Metabolic Research in Diabetes within the Diabetes Program at Karolinska Institutet. He currently serves as the Honorary Secretary of the European Association for the Study of Diabetes (EASD) and is a member of the Nobel Assembly at the Karolinska Institute.

« Go Back